Avior Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.04M | Buy |
4,061
+23
| +0.6% | +$11K | 0.05% | 244 |
|
|
2026
Q1 | $1.98M | Sell |
4,038
-358
| -8% | -$194K | 0.06% | 255 |
|
|
2025
Q4 | $2.55M | Sell |
4,396
-61
| -1% | -$34.5K | 0.08% | 172 |
|
|
2025
Q3 | $2.16M | Buy |
4,457
+361
| +9% | +$168K | 0.07% | 185 |
|
|
2025
Q2 | $1.66M | Buy |
4,096
+806
| +24% | +$337K | 0.06% | 203 |
|
|
2025
Q1 | $1.64M | Sell |
3,290
-635
| -16% | -$344K | 0.06% | 197 |
|
|
2024
Q4 | $2.04M | Sell |
3,925
-31
| -0.8% | -$17K | 0.07% | 174 |
|
|
2024
Q3 | $2.45M | Buy |
3,956
+30
| +0.8% | +$17.8K | 0.1% | 147 |
|
|
2024
Q2 | $2.17M | Sell |
3,926
-325
| -8% | -$186K | 0.09% | 155 |
|
|
2024
Q1 | $2.47M | Buy |
4,251
+313
| +8% | +$176K | 0.11% | 141 |
|
|
2023
Q4 | $2.09M | Buy |
3,938
+126
| +3% | +$61K | 0.13% | 130 |
|
|
2023
Q3 | $1.93M | Buy |
3,812
+1,112
| +41% | +$593K | 0.13% | 124 |
|
|
2023
Q2 | $1.41M | Sell |
2,700
-50
| -2% | -$27K | 0.09% | 154 |
|
|
2023
Q1 | $1.59M | Buy |
2,750
+373
| +16% | +$210K | 0.11% | 144 |
|
|
2022
Q4 | $1.31M | Sell |
2,377
-40
| -2% | -$21.2K | 0.1% | 158 |
|
|
2022
Q3 | $1.22M | Sell |
2,417
-90
| -4% | -$50.4K | 0.1% | 145 |
|
|
2022
Q2 | $1.36M | Buy |
2,507
+10
| +0.4% | +$5.5K | 0.14% | 121 |
|
|
2022
Q1 | $1.47M | Buy |
2,497
+165
| +7% | +$94.8K | 0.13% | 128 |
|
|
2021
Q4 | $1.55M | Buy |
2,332
+149
| +7% | +$93K | 0.13% | 129 |
|
|
2021
Q3 | $1.25M | Buy |
2,183
+1,454
| +199% | +$798K | 0.1% | 152 |
|
|
2021
Q2 | $367K | Sell |
729
-65
| -8% | -$30.7K | 0.04% | 341 |
|
|
2021
Q1 | $361K | Sell |
794
-39
| -5% | -$18.6K | 0.04% | 343 |
|
|
2020
Q4 | $387K | Sell |
833
-80
| -9% | -$37.5K | 0.05% | 314 |
|
|
2020
Q3 | $402K | Sell |
913
-201
| -18% | -$83K | 0.06% | 281 |
|
|
2020
Q2 | $403K | Sell |
1,114
-106
| -9% | -$35.5K | 0.06% | 278 |
|
|
2020
Q1 | $345K | Sell |
1,220
-215
| -15% | -$67.8K | 0.07% | 253 |
|
|
2019
Q4 | $466K | Hold |
1,435
| – | – | 0.07% | 238 |
|
|
2019
Q3 | $417K | Sell |
1,435
-39
| -3% | -$11.2K | 0.07% | 244 |
|
|
2019
Q2 | $432K | Sell |
1,474
-52
| -3% | -$14.3K | 0.08% | 232 |
|
|
2019
Q1 | $416K | Buy |
1,526
+65
| +4% | +$16.2K | 0.09% | 228 |
|
|
2018
Q4 | $326K | Buy |
1,461
+26
| +2% | +$6.1K | 0.08% | 233 |
|
|
2018
Q3 | $350K | Sell |
1,435
-244
| -15% | -$56.1K | 0.07% | 236 |
|
|
2018
Q2 | $348K | Sell |
1,679
-8
| -0.5% | -$1.7K | 0.08% | 224 |
|
|
2018
Q1 | $348K | Sell |
1,687
-147
| -8% | -$30.9K | 0.08% | 214 |
|
|
2017
Q4 | $348K | Buy |
+1,834
| New | +$351K | 0.08% | 220 |
|
Other funds holding TMO
Avior Wealth Management's TMO Position: Q2 2026 in Review
Avior Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 0.57% in Q2 2026, buying an estimated $11K and bringing the position to 4,061 shares worth $2.04M. The position accounts for 0.05% of the portfolio, ranked #244.
Avior Wealth Management first reported a position in TMO in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.55M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Avior Wealth Management held 4,061 shares of Thermo Fisher Scientific worth $2.04M as of Q2 2026.
- Avior Wealth Management bought 23 Thermo Fisher Scientific shares in Q2 2026, an estimated $11K.
- Thermo Fisher Scientific made up 0.05% of Avior Wealth Management's portfolio in Q2 2026, its #244 holding.
- Avior Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 35 quarters since.
- Avior Wealth Management's Thermo Fisher Scientific position peaked at $2.55M in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.